Finance Partner Les Jacobowitz spoke with Banking New York after attorneys general in at least five states began conducting investigations tied to alleged manipulation of the London interbank offered rate (LIBOR), adding to probes by US and UK authorities.
The Securities and Exchange Commission (SEC) issued proposed regulations earlier this month that would amend three of the disclosure items required under Regulation S-K:
Arent Fox Partner Jenny Lee and Associate Susan Tran recently wrote the article, “Consumer Protection in the New Economy: Privacy Cases in E-Commerce Transactions or Social Media Activities,” that was published in The Consumer Finance Quarterly Report, Volume 73, No. 1.
The New York Law Journal reported last year that Arent Fox’s Les Jacobowitz asked but no one—not class counsel, the judge, and certainly not the banks—had an answer.
Biosimilars Review & Report
Land Use Counsel Tim Tosta was recently quoted in the San Francisco Business Journal article, “San Bruno reels from councilman’s veto of huge housing project,” published on July 11, 2019.
Pfizer’s recent decision not to disclose data about Enbrel’s potential to treat Alzheimer’s disease has caused much debate about drugmakers’ obligations to the public.
The Center for Biosimilars
Arent Fox Associate Emily Leongini was quoted in the Hemp Industry Daily article, “Restaurant CBD sales are booming, but new liability concerns keep cannabis producers from cashing in,” published on June 10, 2019.
Thomson Reuters recently sat down with M. Scott Peeler to discuss his role in advancing diverse talent, driving inclusion, and helping to implement the Mansfield Rule’s internal target of 30% diverse talent slates for all leadership positions at the firm.
Arent Fox Associate Emily Leongini was quoted in the Atlanta Journal-Constitution article, “Confusion continues over the legality of CBD products,” published on May 31, 2019.
Partners Robert Capers and Hunter Carter were interviewed for a profile article by El Comercio during their recent business trip in Peru.
Arent Fox Associate Emily Leongini was quoted in the Hemp Industry Daily article, “Five things CBD insiders are looking for from the FDA,” published on May 21, 2019.